News

AbbVie (ABBV) delivered impressive financial results for the first quarter of 2025. Investors responded enthusiastically, ...
AbbVie announced that the FDA approved Emblaveo (aztreonam and avibactam), as the first monobactam/β-lactamase inhibitor combination antibiotic therapy to treat complicated intra-abdominal ...
Novo Nordisk is waiting for a decision on Awiqli from the FDA next month ... also backed approval of Pfizer’s antibiotic infusion Emblaveo (aztreonam-avibactam) to treat complicated intra ...
Kennedy Jr.'s goals to swap them out with natural alternatives in the U.S. food supply. The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy ...
"There were no layoffs to scientists or food inspectors," FDA Commissioner Dr. Marty Makary told CNN on Wednesday. Makary previously said in an April 17 interview with Megyn Kelly that there "were ...
The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency ...
The latest shipments of counterfeit Ozempic seized by the FDA, identified by a specific combination of lot and serial numbers. © Food and Drug Administration Buyer ...
Now, the U.S. Food and Drug Administration is warning the public about the risks. The FDA warning is about a topical spray version of finasteride, a drug often sold online by telehealth companies ...
Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail. The medication accounted for 63 percent of U.S. abortions in 2023.
The Food Emergency Response Network Proficiency Testing Program is currently in the process of transferring to another lab that will allow the program to continue, an FDA spokesperson confirmed in ...